Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2025 06:00 ET | Source: Tower Semiconductor

Tower Semiconductor to Attend the 28th Annual Needham Growth Conference

MIGDAL HAEMEK, Israel, December 29, 2025 – Tower Semiconductor (NASDAQ/TASE: TSEM), the leading foundry of high value analog semiconductor solutions, today announced that its company representatives...
December 29, 2025 06:00 ET | Source: Twin Hospitality Group Inc.

Twin Hospitality Group Announces Leadership Updates

Andy Wiederhorn Appointed Chief Executive Officer; Roger Gondek to Assume Twin Peaks President Role DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Twin Hospitality Group Inc. (Nasdaq: TWNP), the parent...
December 29, 2025 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

STAFFORD, Texas, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
December 29, 2025 06:00 ET | Source: Adlai Nortye Ltd.

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company...
December 29, 2025 05:57 ET | Source: Datavault AI Inc.

Datavault AI Inc. Announces Board Approval of Dividend of Dream Bowl Meme Coin II to All Eligible Record Equity Holders of Datavault AI

PHILADELPHIA, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT), a leader in data monetization, credentialing, and digital engagement technologies,...
December 29, 2025 03:35 ET | Source: HUTCHMED (China) Limited

HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma

— NDA supported by results from a Phase II registration trial in China — — Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in...
December 28, 2025 20:15 ET | Source: CEA Industries Inc.

CEA Industries (BNC) Adopts Stockholder Rights Plan and Amended and Restated Bylaws in Response to YZi Labs Group Formation

Rights plan protects the Company and its stockholders from a change of control without a control premium Amended and Restated Bylaws ensure orderly and informed consent solicitation LOUISVILLE, CO,...
December 26, 2025 17:55 ET | Source: MEDIROM Healthcare Technologies Inc.

MEDIROM Partners with World

TOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), a diversified healthcare...
December 26, 2025 17:44 ET | Source: Fennec Pharmaceuticals Inc.

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)

NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on...
December 26, 2025 17:00 ET | Source: Outlook Therapeutics, Inc.

Outlook Therapeutics Announces New Employment Inducement Grants

ISELIN, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...